Brigid A. Makes has served on our board of directors since June 2021. Ms. Makes served as Chief Financial Officer of Vivani Medical Inc., a Nasdaq listed pharmaceutical company (VANI) from August 2022 through August 2025. Vivani merged with Nano Precision Medical Inc., a private bio pharmaceutical company, where Ms. Makes served as a part-time Chief Financial Officer. Ms. Makes has served as an independent consultant for medical device and healthcare companies since July 2017, specifically advising on financial, funding and strategic responsibilities. From September 2011 to July 2017, Ms. Makes served as Senior Vice President and Chief Financial Officer of Miramar Labs, Inc., a biotechnology company focused on aesthetics and dermatology. From 2006 to 2011, Ms. Makes served as Senior Vice President and Chief Financial Officer of AGA Medical Corporation, a medical device company developing interventional devices for the minimally invasive treatment of structural heart defects and peripheral vascular disorders. Prior to joining AGA, Ms. Makes held various positions at Nektar Therapeutics Inc., a biopharmaceutical company, from 1999 to 2006, including serving as Chief Financial Officer. Prior to 1999, Ms. Makes also served as Chief Financial Officer at Oravax Inc., a vaccine company, and Haemonetics Corporation, a provider of blood and plasma supplies and services.
Ms. Makes also currently serves on the board of directors of Elutia Inc. (formerly Aziyo Biologics). Ms. Makes holds an M.B.A. in finance from Bentley University and a Bachelor of Commerce degree in finance & international business from McGill University. Ms. Makes’ qualifications to serve on our board of directors include her extensive executive leadership experience in the healthcare and life sciences industries, her significant corporate finance experience, and her experience serving on the board of directors of other publicly traded companies.
